These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21115884)

  • 1. MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma.
    Tivnan A; Foley NH; Tracey L; Davidoff AM; Stallings RL
    Anticancer Res; 2010 Nov; 30(11):4391-5. PubMed ID: 21115884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma.
    Tivnan A; Tracey L; Buckley PG; Alcock LC; Davidoff AM; Stallings RL
    BMC Cancer; 2011 Jan; 11():33. PubMed ID: 21266077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network Modeling of microRNA-mRNA Interactions in Neuroblastoma Tumorigenesis Identifies miR-204 as a Direct Inhibitor of MYCN.
    Ooi CY; Carter DR; Liu B; Mayoh C; Beckers A; Lalwani A; Nagy Z; De Brouwer S; Decaesteker B; Hung TT; Norris MD; Haber M; Liu T; De Preter K; Speleman F; Cheung BB; Marshall GM
    Cancer Res; 2018 Jun; 78(12):3122-3134. PubMed ID: 29610116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.
    Zhang H; Pu J; Qi T; Qi M; Yang C; Li S; Huang K; Zheng L; Tong Q
    Oncogene; 2014 Jan; 33(3):387-97. PubMed ID: 23222716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
    Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
    Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma.
    Bray I; Tivnan A; Bryan K; Foley NH; Watters KM; Tracey L; Davidoff AM; Stallings RL
    Cancer Lett; 2011 Apr; 303(1):56-64. PubMed ID: 21310526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional high-throughput screening reveals miR-323a-5p and miR-342-5p as new tumor-suppressive microRNA for neuroblastoma.
    Soriano A; Masanas M; Boloix A; Masiá N; París-Coderch L; Piskareva O; Jiménez C; Henrich KO; Roma J; Westermann F; Stallings RL; Sábado C; de Toledo JS; Santamaria A; Gallego S; Segura MF
    Cell Mol Life Sci; 2019 Jun; 76(11):2231-2243. PubMed ID: 30770954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA RMRP silence curbs neonatal neuroblastoma progression by regulating microRNA-206/tachykinin-1 receptor axis via inactivating extracellular signal-regulated kinases.
    Pan J; Zhang D; Zhang J; Qin P; Wang J
    Cancer Biol Ther; 2019; 20(5):653-665. PubMed ID: 30582709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells.
    Buechner J; Henriksen JR; Haug BH; Tømte E; Flaegstad T; Einvik C
    Differentiation; 2011 Jan; 81(1):25-34. PubMed ID: 20980091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms.
    Neviani P; Wise PM; Murtadha M; Liu CW; Wu CH; Jong AY; Seeger RC; Fabbri M
    Cancer Res; 2019 Mar; 79(6):1151-1164. PubMed ID: 30541743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
    Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
    Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.
    Foley NH; Bray IM; Tivnan A; Bryan K; Murphy DM; Buckley PG; Ryan J; O'Meara A; O'Sullivan M; Stallings RL
    Mol Cancer; 2010 Apr; 9():83. PubMed ID: 20409325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest.
    Zhao Z; Ma X; Sung D; Li M; Kosti A; Lin G; Chen Y; Pertsemlidis A; Hsiao TH; Du L
    RNA Biol; 2015; 12(5):538-54. PubMed ID: 25760387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes.
    Soriano A; París-Coderch L; Jubierre L; Martínez A; Zhou X; Piskareva O; Bray I; Vidal I; Almazán-Moga A; Molist C; Roma J; Bayascas JR; Casanovas O; Stallings RL; Sánchez de Toledo J; Gallego S; Segura MF
    Oncotarget; 2016 Feb; 7(8):9271-87. PubMed ID: 26824183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-205 Inhibits Neuroblastoma Growth by Targeting cAMP-Responsive Element-Binding Protein 1.
    Chen S; Jin L; Nie S; Han L; Lu N; Zhou Y
    Oncol Res; 2018 Apr; 26(3):445-455. PubMed ID: 28653600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-content morphological screen identifies novel microRNAs that regulate neuroblastoma cell differentiation.
    Zhao Z; Ma X; Hsiao TH; Lin G; Kosti A; Yu X; Suresh U; Chen Y; Tomlinson GE; Pertsemlidis A; Du L
    Oncotarget; 2014 May; 5(9):2499-512. PubMed ID: 24811707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of miR-144 on proliferation, apoptosis and cisplatin resistance by targeting MYCN in pediatric neuroblastoma].
    Liu HJ; Li GL; Lei PC
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):516-521. PubMed ID: 31357838
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a Simple and Reproducible Cell-derived Orthotopic Xenograft Murine Model for Neuroblastoma.
    Doyle K; Hassan AE; Sutter M; Rodriguez M; Kumar P; Brown E
    In Vivo; 2024; 38(2):531-538. PubMed ID: 38418146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A.
    Yang H; Li Q; Zhao W; Yuan D; Zhao H; Zhou Y
    FEBS Lett; 2014 Jan; 588(1):192-7. PubMed ID: 24316513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200a inhibits tumor proliferation by targeting AP-2γ in neuroblastoma cells.
    Gao SL; Wang LZ; Liu HY; Liu DL; Xie LM; Zhang ZW
    Asian Pac J Cancer Prev; 2014; 15(11):4671-6. PubMed ID: 24969902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.